Please login or register first to view this content.
Hematological Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Rilzabrutinib Fast Tracked for Immune Thrombocytopenia
Pegcetacoplan Gets Priority Review for Paroxysmal Nocturnal Hemoglobinuria
Manufacturing Deficiencies Delay Decision on Sutimlimab for Cold Agglutinin Disease
Endari Label Updated With Benefit Statement, Instructions for Use
Rifaximin Gets Orphan Drug Status for Sickle Cell Disease
Immunogenicity Data Added to Nuwiq Labeling
Siklos Now Available in 100mg Scored Tablets
Individuals With Blood Group O Have Lower Risk for COVID-19
FDA Approves New Formulation of Ultomiris for PNH and aHUS
FDA: More Data on Remestemcel-L for Graft Versus Host Disease Needed
SARS-CoV-2 Antibody Testing Linked to Increase in First-Time Blood Donors
Generic Version of Ferriprox Now Available
Haegarda Approved for Pediatric Hereditary Angioedema
FDA Approves Nucala for Hypereosinophilic Syndrome
Factors Contributing to Darbepoetin Responsiveness in CKD
Vadadustat Noninferior to Darbepoetin in CKD
Medical Marijuana Tied to Fewer Admissions in Sickle Cell Disease
Label Mix-Up Prompts Recall of IV Amiodarone, Tranexamic Acid
